menu
    • menu

    Company profile for Cosentyx

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    COSENTYX® Connect has partnered with the top-rated medication-tracking app to help you get even more support when you want it—throughout your treatment Once you’re prescribed COSENTYX, download the Medisafe app for free from the App Store or Google Play Store, and add COSENTYX to your Med Cabinet. You can start taking advantage of tools and services right away, to help you get started with treatment and stay on track thr...
    COSENTYX® Connect has partnered with the top-rated medication-tracking app to help you get even more support when you want it—throughout your treatment Once you’re prescribed COSENTYX, download the Medisafe app for free from the App Store or Google Play Store, and add COSENTYX to your Med Cabinet. You can start taking advantage of tools and services right away, to help you get started with treatment and stay on track throughout your journey.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CosentyxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    --
    Telephone
    Telephone
    1-888-669-6682
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cosentyx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Novartis: 2023 Growth, 40% Core Margin, Pipeline Wins
    Novartis: 2023 Growth, 40% Core Margin, Pipeline Wins

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231748/0/en/Novartis-delivered-high-single-digit-sales-growth-achieved-40-core-margin-and-further-advanced-the-pipeline-in-2025.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Novartis' Cosentyx® Succeeds In Phase III Trial For PMR
    Novartis' Cosentyx® Succeeds In Phase III Trial For PMR

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3170800/0/en/Novartis-Cosentyx-meets-primary-and-all-secondary-endpoints-in-Phase-III-trial-in-patients-with-polymyalgia-rheumatica-PMR.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    Novartis Launches Direct-To-Patient Platform For Cosentyx In US
    Novartis Launches Direct-To-Patient Platform For Cosentyx In US

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157703/0/en/Novartis-to-launch-Direct-to-Patient-platform-for-Cosentyx-secukinumab-in-the-US.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices
    Novartis, Boehringer Debut DTC Programs With Reduced Drug Prices

    29 Sep 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/novartis-boehringer-dtc-platforms-slash-prices-cosentyx-spiriva-respimat

    FIERCE PHARMA
    29 Sep 2025
    Share Share
    Novartis' Pluvicto Picks up Speed, Delivers Another Trial Win
    Novartis' Pluvicto Picks up Speed, Delivers Another Trial Win

    17 Jul 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/novartis-pluvicto-finally-picks-speed-delivers-another-trial-win-early-prostate-cancer

    FIERCE PHARMA
    17 Jul 2025
    Share Share
    Patients with hidradenitis suppurativa experienced efficacy with Cosentyx
    Patients with hidradenitis suppurativa experienced efficacy with Cosentyx

    03 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/03/2601665/0/en/Patients-with-hidradenitis-suppurativa-experienced-sustained-efficacy-and-symptom-improvement-at-one-year-when-treated-with-Novartis-Cosentyx.html

    GLOBENEWSWIRE
    03 Feb 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search